Petra Denig (P Denig)

ResearcherID Scopus Author ID Researcher ID DAI ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 28

Top Topics

Top Venues

Pharmacoepidemiology and drug safety

British journal of clinical pharmacology

Journal of diabetes research

This page only lists publications with an associated author ORCID identifier.

Publications

Taichi Ochi, Stijn de Vos, Daniel J Touw, Petra Denig, Talitha L Feenstra, Eelko Hak
Tailoring Type II Diabetes Treatment: Investigating the Effect of 5-HTT Polymorphisms on HbA1c Levels after Metformin Initiation. Journal of diabetes research 2024 (2024)
Sieta T de Vries, Stijn de Vos, Monika Pury Oktora, Petra Denig
Sex disparities in medication changes after metformin initiation are associated with small, clinically non-relevant, sex differences in HbA1c levels during follow-up. Pharmacoepidemiology and drug safety 33 (5) (2024)
Taichi Ochi, Stijn de Vos, Daniel J Touw, Petra Denig, Talitha L Feenstra, Eelko Hak
Tailoring Type II Diabetes Treatment: Investigating the Effect of 5-HTT Polymorphisms on HbA1c Levels after Metformin Initiation. Journal of diabetes research 2024 (2024)
Sieta T de Vries, Stijn de Vos, Monika Pury Oktora, Petra Denig
Sex disparities in medication changes after metformin initiation are associated with small, clinically non-relevant, sex differences in HbA1c levels during follow-up. Pharmacoepidemiology and drug safety 33 (5) (2024)
Taichi Ochi, Stijn de Vos, Daniel J Touw, Petra Denig, Talitha L Feenstra, Eelko Hak
Tailoring Type II Diabetes Treatment: Investigating the Effect of 5-HTT Polymorphisms on HbA1c Levels after Metformin Initiation. Journal of diabetes research 2024 (2024)
Fan Zhang, Geertruida H de Bock, Petra Denig, Gijs W Landman, Qing-Ying Zhang, Grigory A Sidorenkov
Role of Serum Lipids, Blood Glucose and Blood Pressure in Breast Cancer Risk for Women with Type 2 Diabetes Mellitus. Clinical epidemiology 15 (2023)
Monika Pury Oktora, Stijn de Vos, Sieta T de Vries, Eelko Hak, Petra Denig
Sex disparities in treatment patterns after metformin initiation among patients with type 2 diabetes mellitus. Pharmacoepidemiology and drug safety (2023)
Fan Zhang, Geertruida H de Bock, Petra Denig, Gijs W Landman, Qing-Ying Zhang, Grigory A Sidorenkov
Role of Serum Lipids, Blood Glucose and Blood Pressure in Breast Cancer Risk for Women with Type 2 Diabetes Mellitus. Clinical epidemiology 15 (2023)
Esther de Vries, Elisabeth Bakker, Reynold D C Francisca, Stijn Croonen, Petra Denig, Peter G M Mol
Handling of New Drug Safety Information in the Dutch Hospital Setting: A Mixed Methods Approach. Drug safety 45 (4) (2022)
Esther de Vries, Elisabeth Bakker, Taco B M Monster, Petra Denig, Peter G M Mol
Factors Influencing Preferences and Responses Towards Drug Safety Communications: A Conjoint Experiment Among Hospital-Based Healthcare Professionals in the Netherlands. Drug safety 45 (11) (2022)
Martina Ambrož, Marit Geelink, Kirsten P J Smits, Sieta T de Vries, Petra Denig
Sex disparities in medication prescribing amongst patients with type 2 diabetes mellitus managed in primary care. Diabetic medicine : a journal of the British Diabetic Association (2022)
Esther de Vries, Petra Denig, Sieta T de Vries, Taco B M Monster, Jacqueline Geertruida Hugtenburg, Peter G M Mol
Drug Safety Issues Covered by Lay Media: A Cohort Study of Direct Healthcare Provider Communications Sent between 2001 and 2015 in The Netherlands. Drug safety 43 (7) (2021)
Stijn Crutzen, Sunil B Nagaraj, Katka Taxis, Petra Denig
Identifying patients at increased risk of hypoglycaemia in primary care: Development of a machine learning-based screening tool. Diabetes/metabolism research and reviews 37 (7) (2021)
Sieta T de Vries, Petra Denig, Corine Ekhart, Peter G M Mol, Eugene P van Puijenbroek
Sex Differences in Adverse Drug Reactions of Metformin: A Longitudinal Survey Study. Drug safety 43 (5) (2021)
Sofa Dewi Alfian, Nurul Annisa, Aulia Iskandarsyah, Dyah Aryani Perwitasari, Petra Denig, Eelko Hak, Rizky Abdulah
Emotional Distress is Associated with Lower Health-Related Quality of Life Among Patients with Diabetes Using Antihypertensive and/or Antihyperlipidemic Medications: A Multicenter Study in Indonesia. Therapeutics and clinical risk management 17 (2021)
Jing de Haan-Du, Gijs W D Landman, Nanne Kleefstra, Dennis Schrijnders, Marjolijn Manders, Amanda C R K Bos, Cathrien Tromp-van Driel, Petra Denig, Klaas H Groenier, Geertruida H de Bock
Glycemic Control for Colorectal Cancer Survivors Compared to Those without Cancer in the Dutch Primary Care for Type 2 Diabetes: A Prospective Cohort Study. Cancers 13 (11) (2021)
Martina Ambrož, Sieta T de Vries, Priya Vart, Robin P F Dullaart, Jeanine E Roeters van Lennep, Petra Denig, Klaas Hoogenberg
Sex Differences in Lipid Profile across the Life Span in Patients with Type 2 Diabetes: A Primary Care-Based Study. Journal of clinical medicine 10 (8) (2021)
Sieta T de Vries, Petra Denig, Adriana Andrić, Marina Dimov Di Giusti, Alicia Ptaszynska-Neophytou, Linda Härmark, Peter G M Mol, null null
Motives to Report Adverse Drug Reactions to the National Agency: A Survey Study among Healthcare Professionals and Patients in Croatia, The Netherlands, and the UK. Drug safety 44 (10) (2021)
Monika Pury Oktora, Sofa Dewi Alfian, H Jens Bos, Catharina Carolina Maria Schuiling-Veninga, Katja Taxis, Eelko Hak, Petra Denig
Trends in polypharmacy and potentially inappropriate medication (PIM) in older and middle-aged people treated for diabetes. British journal of clinical pharmacology 87 (7) (2020)
Monika Pury Oktora, K P Kerr, Eelko Hak, Petra Denig
Rates, determinants and success of implementing deprescribing in people with type 2 diabetes: A scoping review. Diabetic medicine : a journal of the British Diabetic Association 38 (2) (2020)
Sofa Dewi Alfian, Job F M van Boven, Rizky Abdulah, Hadyana Sukandar, Petra Denig, Eelko Hak
Effectiveness of a targeted and tailored pharmacist-led intervention to improve adherence to antihypertensive drugs among patients with type 2 diabetes in Indonesia: A cluster randomised controlled trial. British journal of clinical pharmacology 87 (4) (2020)
Martina Ambrož, Sieta T de Vries, Grigory A Sidorenkov, Klaas Hoogenberg, Petra Denig
Changes in blood pressure thresholds for initiating antihypertensive medication in patients with diabetes: a repeated cross-sectional study focusing on the impact of age and frailty. BMJ open 10 (9) (2020)
Martina Ambrož, Sieta T de Vries, Klaas Hoogenberg, Petra Denig
Trends in HbA1c thresholds for initiation of hypoglycemic agents: Impact of changed recommendations for older and frail patients. Pharmacoepidemiology and drug safety 30 (1) (2020)
Sieta T de Vries, Judy Harrison, Patrick Revelle, Alicia Ptaszynska-Neophytou, Anna Radecka, Gowthamei Ragunathan, Phil Tregunno, Petra Denig, Peter G M Mol
Use of a Patient-Friendly Terms List in the Adverse Drug Reaction Report Form: A Database Study. Drug safety 42 (7) (2020)
Petra Denig, Eugene P van Puijenbroek, Nashwa Soliman, Peter G M Mol, Sieta T de Vries
Adverse drug event patterns experienced by patients with diabetes: A diary study in primary care. Pharmacoepidemiology and drug safety 28 (9) (2019)
Sieta T de Vries, Petra Denig, Corine Ekhart, Jako S Burgers, Nanne Kleefstra, Peter G M Mol, Eugene P van Puijenbroek
Sex differences in adverse drug reactions reported to the National Pharmacovigilance Centre in the Netherlands: An explorative observational study. British journal of clinical pharmacology 85 (7) (2019)
Katinka J Nauta, Feikje Groenhof, Jan Schuling, Jacqueline G Hugtenburg, Hein P J van Hout, Flora M Haaijer-Ruskamp, Petra Denig
Application of the STOPP/START criteria to a medical record database. Pharmacoepidemiology and drug safety 26 (10) (2017)
Anita Wildeboer, Esther du Pon, Jan Schuling, Flora M Haaijer-Ruskamp, Petra Denig
Views of general practice staff about the use of a patient-oriented treatment decision aid in shared decision making for patients with type 2 diabetes: A mixed-methods study. Health expectations : an international journal of public participation in health care and health policy 21 (1) (2017)